These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10529754)

  • 1. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment.
    Stankoff B; Calvez V; Suarez S; Bossi P; Rosenblum O; Conquy L; Turell E; Dubard T; Coutellier A; Baril L; Bricaire F; Lacomblez L; Lubetzki C
    Eur J Neurol; 1999 Nov; 6(6):669-75. PubMed ID: 10529754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF, plasma viral load and HIV associated dementia.
    Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
    J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
    Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
    Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.
    Cinque P; Vago L; Ceresa D; Mainini F; Terreni MR; Vagani A; Torri W; Bossolasco S; Lazzarin A
    AIDS; 1998 Mar; 12(4):389-94. PubMed ID: 9520168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.
    Gelman BB; Lisinicchia JG; Morgello S; Masliah E; Commins D; Achim CL; Fox HS; Kolson DL; Grant I; Singer E; Yiannoutsos CT; Sherman S; Gensler G; Moore DJ; Chen T; Soukup VM
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):487-95. PubMed ID: 23242157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.
    Conrad AJ; Schmid P; Syndulko K; Singer EJ; Nagra RM; Russell JJ; Tourtellotte WW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):425-35. PubMed ID: 7583438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.
    Lentz MR; Degaonkar M; Mohamed MA; Kim H; Conant K; Halpern EF; Sacktor N; Barker PB; Pomper MG
    J Neurovirol; 2010 Oct; 16(5):368-76. PubMed ID: 20839921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
    Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.
    Goodkin K; Vitiello B; Lyman WD; Asthana D; Atkinson JH; Heseltine PN; Molina R; Zheng W; Khamis I; Wilkie FL; Shapshak P
    J Neurovirol; 2006 Jun; 12(3):178-89. PubMed ID: 16877299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction.
    Kumar AM; Borodowsky I; Fernandez B; Gonzalez L; Kumar M
    J Neurovirol; 2007 Jun; 13(3):210-24. PubMed ID: 17613711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia.
    Suarez SV; Stankoff B; Conquy L; Rosenblum O; Seilhean D; Arvanitakis Z; Lazarini F; Bricaire F; Lubetzki C; Hauw JJ; Dubois B
    Eur J Neurol; 2000 Mar; 7(2):151-8. PubMed ID: 10809935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration.
    Steinbrink F; Evers S; Buerke B; Young P; Arendt G; Koutsilieri E; Reichelt D; Lohmann H; Husstedt IW;
    Eur J Neurol; 2013 Mar; 20(3):420-428. PubMed ID: 23095123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex.
    Krivine A; Force G; Servan J; Cabée A; Rozenberg F; Dighiero L; Marguet F; Lebon P
    J Neurovirol; 1999 Oct; 5(5):500-6. PubMed ID: 10568887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.
    Vitiello B; Goodkin K; Ashtana D; Shapshak P; Atkinson JH; Heseltine PN; Eaton E; Heaton R; Lyman WD
    AIDS; 2007 Jul; 21(11):1415-22. PubMed ID: 17589187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.